Karachi: GlaxoSmithKline Pakistan Limited announced the appointment of Mr. Muhammad Masood Ahmed Khan as an Executive Director on its Board of Directors, effective August 28, 2026. This decision was made to fill a casual vacancy on the board, according to a report released by the company.

Mr. Khan, who currently holds the position of Site Director at GlaxoSmithKline’s Korangi facility, will assume his new responsibilities immediately. The company has communicated this development to the TRE Certificate Holders of the Exchange.

According to information available from the Pakistan Stock Exchange (PSX), the appointment comes as part of the company’s ongoing efforts to strengthen its leadership team. Mr. Khan’s extensive experience with GlaxoSmithKline is expected to contribute significantly to the company's strategic objectives.

GlaxoSmithKline Pakistan Limited, a prominent player in the pharmaceutical sector, remains committed to enhancing its governance and operational frameworks through strategic appointments such as this.